SPONSOR
University Hospital, Clermont-Ferrand
Total Trials
8
Recruiting
8
Phases
Phase 2, Phase 4
Conditions studied: Pancreatic CancerResectable Pancreatic AdenocarcinomaAdenocarcinomaResectable Esophageal CancerResectable Gastric or Gastroesophageal Junction AdenocarcinomaOesophagogastric CancerEsophageal Squamous Cell Carcinoma (ESCC)Heart Rate VariabilityStressMedical Student
University Hospital, Clermont-Ferrand is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Pancreatic Cancer, Resectable Pancreatic Adenocarcinoma, Adenocarcinoma, Resectable Esophageal Cancer.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital, Clermont-Ferrand
How many clinical trials has University Hospital, Clermont-Ferrand sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by University Hospital, Clermont-Ferrand, of which 8 are actively recruiting participants. These trials cover conditions including Pancreatic Cancer, Resectable Pancreatic Adenocarcinoma, Adenocarcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital, Clermont-Ferrand research focus on?
University Hospital, Clermont-Ferrand clinical trials span Pancreatic Cancer, Resectable Pancreatic Adenocarcinoma, Adenocarcinoma, Resectable Esophageal Cancer, Resectable Gastric or Gastroesophageal Junction Adenocarcinoma, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital, Clermont-Ferrand clinical trial?
To participate in a University Hospital, Clermont-Ferrand trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Clermont-Ferrand trials with current recruitment status updated daily.
Clinical Trials by University Hospital, Clermont-Ferrand
NCT06649474
Recruiting
Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1
Pancreatic Cancer
NCT07205731 Phase 2
Recruiting
Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma
Esophageal Squamous Cell Carcinoma (ESCC)
NCT06138457
Recruiting
The ECOSTRESS Study: Influence of the Objective Structured Clinical Examination on Stress Among Medical Student
Heart Rate Variability
NCT05821140
Recruiting
Orofacial Functions and Masticatory Function in Children With Different Types of Deterioration in Oral Health
Mastication
NCT06986980
Recruiting
Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Microsporidiosis Intestinal
NCT07471451
Recruiting
Evolution of Masticatory Function, Orofacial Functions and Quality of Life of Patients Treated for Cancers of the Upper Aerodigestive Tract, Rehabilitated by Maxillofacial Prostheses.
Head and Neck Cancer
NCT07330856 Phase 4
Recruiting
Evaluation of Treatments for Dry or Productive Cough
Cough
NCT06604494
Recruiting
Rehabilitation Improved by Early Detection of Fisyulas Post (Pharyngo) -Total Laryngectomy by Cytokine Measurement on Drainage Fluid on the Second Post-Operative Day
Cancer, Otorhinolaryngeal
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology